Atıf Formatları
Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. Tasyurek Et Al. , "Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes," ESGCT and NVGCT Collaborative Congress , vol.25, The Hague, Netherlands, 2014

Tasyurek, H. Et Al. 2014. Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes. ESGCT and NVGCT Collaborative Congress , (The Hague, Netherlands).

Tasyurek, H., Eksi, Y. E., Sanlioglu, A. D., BALCI, M. K., & Sanlioglu, S., (2014). Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes . ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands

Tasyurek, H. Et Al. "Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes," ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 2014

Tasyurek, H. Et Al. "Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes." ESGCT and NVGCT Collaborative Congress , The Hague, Netherlands, 2014

Tasyurek, H. Et Al. (2014) . "Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes." ESGCT and NVGCT Collaborative Congress , The Hague, Netherlands.

@conferencepaper{conferencepaper, author={H. Tasyurek Et Al. }, title={Therapeutic efficacy of an HIV-based lentivirus mediated vasoactive intestinal peptide gene delivery for diabetes}, congress name={ESGCT and NVGCT Collaborative Congress}, city={The Hague}, country={Netherlands}, year={2014}}